PLAU and neoplasm: Given the evidence linking increased tumor uPA expression with reduced overall survival rates and the consequent inhibitory effect of PAI-1 on uPA, PAI-1 was hypothesized to possess anti-tumor properties that delay cancer progression (4, 5).